The company said clearance from the US Food and Drug Administration for its first in-human clinical study is "an important first step" for its technology.Elon Musk's brain-implant company Neuralink on Thursday said it received the US Food and Drug Administration's (FDA) approval to launch first-in-human clinical study.

Also Read | US: Biden Hails ‘productive’ Debt Talks with McCarthy.

The company announced the decision on Twitter, saying the approval "represents

an important first step that will one day allow our technology to help many people."Also Read | Tillu Tajpuriya Murder Case: 'Shakes My Judicial Conscience', Says Delhi High Court Judge Over the Gangster Being Stabbed Over 90 Times Inside Tihar Jail.

The goal of the company is to develop implants that can treat neural disorders and that may one day be powerful enough to put humanity on a more even footing with possible future superintelligent computers.

On at least four occasions since 2019, Musk has predicted that his medical device company would soon start human trial of a brain impant to treat intractable conditions like paralysis and blindness.

But the company, founded in 2016, did not seek approval until early 2022.

rm/jsi (AFP, Reuters)

(The above story first appeared on LatestLY on May 26, 2023 05:00 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).